Document:

Amend to Common Stock Purchase Warrant No. A-2 dated May 4

 Exhibit 10.5 
  
 AMENDMENT TO COMMON STOCK PURCHASE WARRANT NO. A-2 
  
 THIS AMENDMENT (this “Amendment”) to Common Stock Purchase Warrant No. A-2 (the “Warrant”) is made effective as of the 4th day of May,
2004 by and between OPINION RESEARCH CORPORATION, a Delaware corporation (the “Company”) and ALLIED INVESTMENT CORPORATION, a Maryland corporation (the “Holder”). 
  
 RECITALS 
  
 WHEREAS, pursuant to that certain Investment Agreement (the “Investment Agreement”) dated as of May 26, 1999 by and among the Company, the
Holder and Allied Capital Corporation (together with the Holder, “Allied Entities”), Allied Entities invested in the Company the aggregate sum of $15,000,000 in exchange for certain subordinated debentures and warrants to purchase shares
of Common Stock of the Company; 
  
 WHEREAS, the parties desire to
amend the Warrant upon the terms and conditions set forth below. 
  
 AGREEMENT 
  
 NOW, THEREFORE, in consideration of
the foregoing Recitals and the mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows: 
  
 SECTION 1. Definitions. All capitalized terms used herein without definition shall
have the meanings ascribed to such terms in the Investment Agreement. 
  
 SECTION
2. Amendments to Warrant. The following amendments to the Warrant shall take effect as of the date hereof: 
  
 (a) Section 1 of the Warrant is hereby deleted in its entirety and replaced with the following: 
  
 “1. Grant. For consideration of $100 and other
value received, OPINION RESEARCH CORPORATION, a Delaware corporation (the “Corporation”), hereby grants to ALLIED CAPITAL CORPORATION or its assigns or transferees (the “Holder”), at the exercise price set forth in Section 3
below, the right to purchase 160,244 shares (the “Warrant Shares”) of Common Stock (or other security issued in accordance with Section 8). This Warrant is being issued at Closing under an investment agreement dated as of the date hereof
(the “Investment Agreement”) by and among the Corporation and the Holder. Capitalized terms used herein, 

  

 1 

 
but not elsewhere defined herein or in the Investment Agreement, have the meanings set forth in Schedule 1.” 
  
 (b) Section 2 of the Warrant is hereby deleted in its entirety and replaced
with the following: 
  
 “2. Exercise
Period. The right to exercise this Warrant, in whole or in part, begins on the date hereof. The right to exercise this Warrant expires on the later of (i) May 4, 2009 or (ii) on the third anniversary of the Repayment Date (the “Expiration
Date 
  
 (c) Section 4(b) of the Warrant is hereby deleted in its
entirety and replaced with the following: 
  
 “(b) Intentionally Omitted.” 
  
 (d) Section 5
of the Warrant is hereby modified and amended to insert the following new subsection 5(c) following subsection 5(b): 
  
 “(c) Adjustment for Event of Default. If, pursuant to either of those certain Loan Agreements dated as of May 4, 2004
(together, the “Loan Agreements”) by and among the Borrowers (as defined therein) and the Holders (as defined therein), an Event of Default (as defined therein) occurs under (i) Section 8.1(b) or (c) or (ii) Section 8.1(d) with respect to
a breach of Section 6.12, in each case of the Loan Agreements, the Exercise Price shall be reduced by $1.00 per share (subject to a proportionate adjustment in connection with any adjustment of the Exercise Price under Section 4 or 5 hereof)
immediately after the last day of each consecutive 90 day period during which such Event of Default continues uncured and is not waived by the Holders (and for this purpose such Event of Default shall be deemed to be cured if amounts are paid with
respect to a payment default referred to in Section 8.1(b) or (c) at any time within such 90 day period or if, with respect to a breach of Section 6.12, the Borrowers are in compliance with the covenant in Section 6.12
which was breached as of a date within such 90 day period), provided, however, that the Exercise Price shall not be reduced to below $1.50 per share (subject to a proportionate adjustment in connection with any adjustment of the Exercise Price under
Section 4 or 5 hereof).” 
  
 (e) Schedule 1 of the
Warrant is hereby amended and modified such that the definition of “Repayment Date” is hereby deleted in its entirety and replaced with the following definition of “Repayment Date”: 
  
 ““Repayment Date” means the
date on which the Corporation has repaid in full in cash all amounts outstanding under the Notes (as defined in each of the Loan Agreements).” 
  

 2 

 SECTION 3. Reference to and Effect Upon Warrant. 
  
 (a) Each reference in the Warrant to “this Warrant,” “hereunder,” “hereof,” or words of like
import shall hereafter mean and be a reference to the Warrant, as amended hereby. 
  
 (b) Except as specifically amended hereby or contemplated hereby, the Warrant and each and every term and provision thereof shall remain in full force and effect and are hereby ratified and confirmed. The execution,
delivery, and effectiveness of this Amendment shall not operate as a waiver of any right, power, or remedy of the Holder under the Warrant or any other documents referenced therein or constitute a waiver of any provision of the Warrant. 

 
 SECTION 4. Miscellaneous. 
  
 (a) Entire Agreement; Integration Clause. This Amendment contains the
entire agreement between the parties hereto with respect to this transaction, and as such supersede any prior agreements, whether written or oral, regarding the matters described herein. 
  
 (b) No Oral Modification or Waivers. The terms herein may not be modified or waived orally, but only by an instrument
in writing signed by the party against which enforcement of the modification or waiver (as the case may be) is sought. 
  
 (c) Governing Law. This Amendment is governed by, and interpreted and construed in accordance with, the internal laws of the State of Delaware
(without regard to its conflicts of law principles). 
  
 (d)
Headings. The headings of the paragraphs and sub-paragraphs of this Amendment are inserted for convenience only and shall not be deemed to constitute a part of this Amendment. 
  
 (e) Severability. To the extent any provision herein violates any applicable law, that provision shall be considered
void and the balance of this Amendment shall remain unchanged and in full force and effect. 
  
 (f) Counterparts. This Amendment may be executed in as many counterpart copies as may be required. It shall not be necessary that the signature of, or on behalf of, each party appear on each counterpart, but it
shall be sufficient that the signature of, or on behalf of, each party appear on one or more of the counterparts. All counterparts shall collectively constitute a single agreement. It shall not be necessary in any proof of this Amendment to produce
or account for more than a number of counterparts containing the respective signatures of, or on behalf of, all of the parties. 
  

 3 

 IN WITNESS WHEREOF, the parties have executed and delivered this Amendment as of the date first above
written. 
  

			
	 “COMPANY”:

	
	 OPINION RESEARCH CORPORATION
 a Delaware corporation

		
	By:	 	/s/    KEVIN P. CROKE        
	 Name:
	 	Kevin P. Croke
	 Title:
	 	EVP – Corporate Finance

  

			
	 “HOLDER”:

	
	 ALLIED INVESTMENT CORPORATION
 a Maryland corporation

		
	By:	 	/s/    FRANK IZZO        
	 Name:
	 	Frank Izzo
	 Title:
	 	Principal

  
 SIGNATURE PAGE TO AMENDMENT TO WARRANTEmployment Agreement

 Exhibit 10.1 
  
 EMPLOYMENT AGREEMENT 
  
 This Employment Agreement (“Agreement”) is entered into effective as of March 22, 2004 (the “Effective Date”), by and between
AmeriPath, Inc., a Delaware corporation (“AmeriPath”), and Donald E. Steen (“Employee”), with reference to the following facts: 
  
 R E C I T A L S 
  
 A. AmeriPath desires to employ Employee in the capacities and on the terms and conditions hereinafter set forth and Employee is willing to serve in such
capacities and on such terms and conditions. 
  
 B. Employee
currently serves as a Chairman of the Board of United Surgical Partners International, Inc., a publicly-held Delaware corporation (“USPI”), and Employee intends to remain as Chairman of the Board of USPI during the term of this Agreement.

  
 NOW, THEREFORE, in consideration of the foregoing
premises and the mutual covenants contained herein, AmeriPath and Employee mutually agree as follows: 
  
 A G R E E M E N T 
  
 1. Employment. AmeriPath hereby employs Employee, and Employee accepts employment, as the Chairman of the Board of AmeriPath as of the Effective Date and, effective as of July 1, 2004, as Chief Executive
Officer of AmeriPath. 
  
 2. Duties. 
  
 (a) Nature of Duties. In his capacity as Chairman of the
Board, Employee shall have such duties, responsibilities and authority as are set forth in the Bylaws of AmeriPath and as are typical for the position of Chairman of the Board. In his capacity as Chief Executive Officer, Employee (i) shall report to
the Board of Directors of AmeriPath, (ii) shall have such duties, responsibilities and authority as are set forth in the Bylaws of AmeriPath for the position of Chief Executive Officer and (iii) shall have authority to hire such staff as Employee
determines is necessary and to determine the titles and (subject to established authority levels for setting salaries) the compensation levels of such staff. 
  
 (b) Outside Activities. Anything herein to the contrary notwithstanding, AmeriPath acknowledges and agrees
that Employee shall have the right to remain as Chairman of the Board of USPI at all times during the term of this Agreement. As a result thereof, Employee shall not be obligated to devote all of his business time to his duties under this Agreement.
In addition, AmeriPath will coordinate with Employee in disclosing this Agreement to the Board of Directors of USPI in a manner determined by Employee, and AmeriPath will not make any public announcement or other disclosure of this Agreement without
Employee’s prior approval, which approval will not be unreasonably withheld or delayed or cause AmeriPath to be in violation of federal or state securities laws. In the event of any conflict 

 of interest between AmeriPath and USPI, Employee shall be entitled to refrain from taking any action as to such matter
and shall not be considered to be in breach of any fiduciary or other duty to AmeriPath as a result thereof or as a result of any actions by USPI. 
  
 3. Compensation. 
  
 (a) Base Salary. AmeriPath shall pay Employee a Base Salary (“Base Salary”) at a rate of $445,000 per year; provided, however,
that during any period in which Employee is serving only as Chairman of the Board, his Base Salary shall be at a rate of $278,000 per year. The Board of Directors of AmeriPath shall, in good faith, consider granting increases in such salary based on
Employee’s performance and the growth and/or profitability of AmeriPath, but it shall have no obligation to grant any such increases in compensation. Base Salary shall be payable in equal semi-monthly installments on the 15th day and the last working date of the month, or at such other times and in such installments as may be agreed upon between
AmeriPath and Employee. All payments shall be subject to the deduction of payroll taxes and similar assessments as required by law. 
  
 (b) Performance Bonuses. In addition to the Base Salary, Employee shall be eligible to receive bonus compensation of up to 100% of the Base
Salary based on such performance goals and criteria as the Board of Directors of AmeriPath shall, from time to time, determine. 
  
 4. Expenses and Benefits. AmeriPath agrees to provide Employee with the following benefits: 
  
 (a) Expense Reimbursements. Employee is authorized to incur
reasonable expenses in connection with the business of AmeriPath, including expenses for entertainment, travel and similar matters. AmeriPath will reimburse Employee for such expenses upon presentation by Employee of such documentation as AmeriPath
shall from tune to time require. 
  
 (b) Office
Services. AmeriPath will provide Employee with an administrative assistant of his choice and reasonable office space at AmeriPath’s corporate headquarters office, which is currently located in Riviera Beach, Florida. 

 
 (c) Insurance. Disability insurance and other insurance
programs that are currently in place for AmeriPath’s senior executive officers (as the same may be modified from time to time by AmeriPath for its senior executives). However, so long as Employee obtains health insurance through USPI, Employee
shall not participate in AmeriPath’s health insurance programs. 
  
 (d) Employee Benefit Plans. Participation in any other employee benefit plans now existing or hereafter adopted by AmeriPath for its employees. 
  
 (e) Lodging Expenses. Employee has purchased a condominium in
the West Palm Beach. AmeriPath agrees to pay, or to reimburse Employee, for all condominium fees, utility costs, maintenance and other normal out-of-pocket costs of owning said condominium, which costs the parties estimate will be approximately
$50,000 per year. 
  

 2 

 (f) Vacations. Employee shall be entitled (in addition to the usual public holidays) to a
paid vacation of an aggregate of five weeks in each calendar year. 
  
 (g) Air Travel Expenses. AmeriPath acknowledges that Employee has an ownership interest in a FlexJet Fractional Ownership Program (“FlexJet”) that allows him to use a jet for a designated number of hours per year.
Employee shall be entitled to use up to 50 of such hours for purposes of travel between Dallas, Texas and West Palm Beach, Florida, with the cost of such travel to be paid by Welsh, Carson, Anderson & Stowe IX, L.P. (“WCAS”), which
currently owns 100% of the outstanding common stock of AmeriPath [Holdings, Inc., the parent company of AmeriPath (“Parent”)], and AmeriPath as follows: 
  
 (i) By its execution of this Agreement as set forth below, WCAS agrees to pay to Employee the “wholesale rate”
established by FlexJet for hourly use of said jet by Employee as described above; and 
  
 (ii) AmeriPath shall directly pay to FlexJet the variable cost charged by FlexJet for such usage of said jet by Employee. 
  
 All other travel expenses incurred by Employee shall be reimbursable in accordance with Section 4(a) above. 
  
 (h) Club Initiation Fee. Upon Employee becoming Chief Executive Officer, AmeriPath agrees to pay or
reimburse Employee for the initiation fee at a country club in the West Palm Beach area selected by Employee. Employee shall be responsible for the monthly club membership fees, but other business expenses at such club may be reimbursable as
appropriate pursuant to Section 4(a). Upon termination of this Agreement, Employee shall either (i) give up his membership at said country club and cause any refund of all or a portion of the initiation fee due from the club in connection therewith
to be paid to AmeriPath or (ii) retain such membership and pay to AmeriPath the amount that would have been paid to AmeriPath (as described in clause (i) above) if he had resigned his membership. 
  
 (i) Indemnity Agreement. At or prior to the Effective Date,
Employee and AmeriPath shall enter into an Indemnity Agreement whereunder AmeriPath agrees to indemnify and hold Employee harmless from all liabilities and claims (and costs of defense and expenses related thereto) arising out of the performance by
Employee of his duties hereunder for AmeriPath and its affiliates. Such Indemnity Agreement shall be in form and substance reasonably satisfactory to Employee and AmeriPath. 
  
 5. Term; Severance. The term of this Agreement shall be from the date of this Agreement to June 30,
2007; provided, however, that the term of this Agreement shall be automatically renewed for successive additional one year terms unless a notice of non-renewal is given by either party at least 12 months prior to the end of the initial term or any
such renewal term. Notwithstanding the foregoing, either party may terminate this Agreement upon not less than 90 days notice, but if AmeriPath either gives notice of non-renewal or elects to terminate this Agreement, Employee shall be entitled to
severance pay based on the Base Salary and bonuses that Employee otherwise would have earned pursuant to Section 3 above during the remainder of the term of this Agreement or for 24 months after termination, whichever is longer. Such severance pay
shall be payable in monthly installments and AmeriPath shall continue the 
  

 3 

 benefits set forth in Sections 4(c) for the period during which such severance payments are to be made. A determination
by AmeriPath not to renew or to terminate this Agreement may be made only by an affirmative vote of not less than 75% of the members of the Board of Directors of AmeriPath then in office. In addition, this Agreement may be terminated as provided for
in Section 7 or upon the death of Employee. 
  
 6.
Disability. 
  
 (a) In the event that Employee becomes
Permanently Disabled (as hereinafter defined) during the term of this Agreement, Employee shall continue in the employ of AmeriPath but his compensation hereunder shall be reduced to three-fourths of the Base Salary then in effect as set forth in
Section 3(a), commencing upon the determination of Employee’s Permanent Disability and continuing thereafter until the first to occur of (i) 24 months or (ii) the death of Employee; and during such period of time, Employee shall not be entitled
to payment of expenses or benefits specified in Section 4 (except for reimbursement of expenses incurred by Employee prior to becoming Permanently Disabled), except that AmeriPath shall continue to provide Employee with the insurance benefits
specified in Section 4(c). The obligation of AmeriPath for continuation of three-fourths of Employee’s Base Salary shall be net of payments to Employee from the disability insurance referred to in Section 4(c). 
  
 For purposes of this Agreement, the terms “Permanent Disability” or
“Permanently Disabled” shall mean three months of substantially continuous disability. Disability shall be deemed “substantially continuous” if, as a practical matter, Employee, by reason of his mental or physical health, is
unable to sustain reasonably long periods of substantial performance of his duties. Frequent long illnesses, though different from the preceding illness and though separated by relatively short periods of performance, shall be deemed to be
“substantially continuous.” Disability shall be determined in good faith by the Board of Directors, whose decision shall be final and binding upon Employee. Employee hereby consents to medical examinations by such physicians and medical
consultants as AmeriPath shall, from time to time, require. 
  
 7. Termination by AmeriPath for Cause. AmeriPath shall have the right to terminate Employee’s employment under this Agreement for “Cause” by an affirmative vote to so terminate by not less than 75% of the
members of AmeriPath’s Board of Directors, in which event, no compensation shall be paid or other benefits furnished to Employee after termination for Cause. Termination for Cause shall be effective immediately upon notice sent or given to
Employee. For purposes of this Agreement, the term “Cause” shall mean and be strictly limited to: (a) indictment for a crime constituting a felony under state or federal law; (b) conviction of a crime constituting a misdemeanor and
involving an act of moral turpitude, including without limitation fraud, embezzlement and use of illegal drugs; (c) commission of any material act of dishonesty against AmeriPath; or (d) willful and material breach of this Agreement by Employee.

  
 8. Non-Competition. Employee recognizes
and understands that in performing the responsibilities of his employment, he will occupy a position of fiduciary trust and confidence, pursuant to which he will develop and acquire experience and knowledge with respect to AmeriPath’s
business. It is the expressed intent and agreement of Employee and AmeriPath that such knowledge and experience shall be used exclusively in the furtherance of 
  

 4 

 the interests of AmeriPath and not in any manner which would be detrimental to AmeriPath’s interests. Employee
further understands and agrees that AmeriPath conducts its business within a specialized market segment throughout the United States, and that it would be detrimental to the interests of AmeriPath if Employee used the knowledge and experience which
he currently possesses or which he acquires pursuant to this employment hereunder for the purpose of directly or indirectly competing with AmeriPath, or for the purpose of aiding other persons or entities in so competing with AmeriPath. Employee
therefore agrees that so long as he is employed by AmeriPath and, if this Agreement is terminated by AmeriPath pursuant to Section 5, for an additional period equal to the shorter of one year following termination or for the period of time Employee
is receiving a salary or severance payments from AmeriPath, unless Employee first secures the written consent of AmeriPath, Employee will not directly or indirectly invest, engage or participate in or become employed by any entity in direct or
indirect competition with AmeriPath’s business, which includes the ownership, operation and/or management of anatomic pathology laboratories and information services used by physicians in the detection, evaluation and treatment of cancer and
other diseases and medical conditions. These non-competition provisions shall not be construed to prohibit Employee from being employed in the health care industry during the applicable period, but rather to permit him to be so employed so long as
such employment does not involve Employee’s direct or indirect participation in a business which is the same or similar to AmeriPath’s business (as defined above). In the event that the provisions of this Section 8 should ever be deemed to
exceed the time or geographic limitations permitted by applicable laws, then such provisions shall be reformed to the maximum time or geographic limitations permitted by applicable law. 
  
 9. Stock Options. AmeriPath has granted to Employee stock options covering a number of shares of common stock
of AmeriPath representing 4% of the currently issued and outstanding common stock of AmeriPath, at an exercise price of $6.00 per share. Such stock option grant will (i) be 20% vested on the Effective Date, with the balance to be vested 20% each
year over the initial four year period, (ii) have a 10 year term and (iii) be evidenced by a Stock Option Agreement in a form reasonably acceptable to both parties that is to be prepared by AmeriPath and entered into by Employee and AmeriPath. In
the event that there is a “Change of Control Event” (as defined below), all AmeriPath stock options held by Employee (whether granted subject to forfeiture or vesting) shall thereupon automatically be amended so as (a) to vest, immediately
prior to the date of such Change in Control Event, all then unvested stock options and (b) to provide Employee 90 days to exercise such options (or such greater period as may be provided by the terms of such options). 
  
 For purposes of this Section 9, the term “Change of Control Event”
shall mean (1) a consolidation or merger of either AmeriPath or its parent company (“Parent”), which currently is AmeriPath Holdings, Inc., with or into any other entity (other than a merger which will not result in more than 50% of the
voting capital stock of AmeriPath or Parent outstanding immediately after the effective date of such merger being owned of record or beneficially by persons other than the holders of such voting capital stock immediately prior to such merger in the
same proportions in which such shares were held immediately prior to such merger), (2) a sale of all or substantially all of the properties and assets of AmeriPath as an entirety in a single transaction or in a series or related transactions to any
other person or (3) the acquisition of “beneficial ownership” by any “person” or “group” (other than WCAS or its affiliates) of voting stock of AmeriPath or Parent representing more than 50% of the voting power of all
outstanding shares of such voting stock, whether by way of merger, tender offer, purchase of shares from AmeriPath or Parent or otherwise. 
  

 5 

 As used herein, (1) the terms “person” and “group” shall have the meaning set forth
in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), whether or not applicable, (2) the term “beneficial owner” shall have the meaning set forth in Rules 13d-3 and 13d-5 under the Exchange
Act, whether or not applicable, except that a person shall be deemed to have “beneficial ownership” of all shares that any such person has the right to acquire, whether such right is excisable immediately or only after the passage of time
or upon the occurrence of certain events, and (3) any “person” or “group” will be deemed to beneficially own any voting stock of AmeriPath or Parent so long as such person or group beneficially owns, directly or indirectly, in
the aggregate a majority of the voting stock of a registered holder of the voting stock of AmeriPath or Parent. 
  
 10. General Provisions. 
  
 (a) Notices. All notices required or permitted by this Agreement shall be in writing and may be delivered in person or sent by regular,
registered or certified mail or United States Postal Service Express Mail, with postage prepaid, or by other courier service, or by facsimile transmission, and shall be deemed sufficiently given if served in the manner specified in this Section
10(a). The addresses and facsimile numbers set forth below shall be the parties addressed and facsimile numbers for purposes for purposes of delivery or mailing of notices: 
  

			
	 If to AmeriPath:
	 	 AmeriPath, Inc.

	 	 	 7289 Garden Road, Suite 200

	 	 	 Riviera Beach, Florida 33404

	 	 	 Attention: Joseph A. Sonnier, M.D., President

	 	 	 Fax No.: (561)
                    

		
	 If to Employee:
	 	 Donald E. Steen

	 	 	 5715 Thames Court

	 	 	 Dallas, Texas 75252

	 	 	 Fax No.: (972)248-8868

  
 The parties may change addresses and
facsimile numbers noted above through written notice in compliance with this Section 10(a). Any notice sent by registered or certified mail, return receipt requested, shall be deemed given when actually received by the addressee, as shown on the
receipt card which must be signed by a representative of the addressee. If sent by regular mail, the notice shall be deemed given after the notice is addressed, mailed with postage prepaid and when actually received by the addressee. Notices
delivered by United States Express Mail, Federal Express or other courier service shall be deemed given when actually received by the addressee as shown by the signature of an authorized representative of the addressee on the log or other
documentation maintained by the United States Postal Service, Federal Express or courier to show proof of delivery. If any notice is transmitted by facsimile transmission or similar means, the notice shall be deemed served or delivered upon
telephone confirmation of receipt of the transmission. 
  

 6 

 (b) Choice of Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of Florida, excluding principles of conflict of laws. 
  
 (c) Integration; Modification and Waiver. This Agreement and the Indemnity Agreement and Stock Option Agreement referred to in Sections 4(i) and 9 constitute the entire understanding of the
parties hereto relating to the subject matter hereof, supersede any and all other agreements, whether oral or in writing, between the parties hereto and their affiliates with respect to the employment of Employee, and contain all covenants and
agreements between the parties hereto relating to such employment in any manner whatsoever; provided, however, that except as expressly provided herein, this Agreement shall not affect any agreements relating to Employee’s purchase or ownership
of AmeriPath securities to which Employee is hereafter a party. This Agreement shall not be amended, modified or revised in any respect, except by a writing signed by AmeriPath and Employee. No waiver of any of the provisions of this Agreement shall
be deemed or shall constitute a waiver of any other provision, whether or not similar, and no waiver shall constitute a continuing waiver. No waiver shall be binding unless executed in writing by the party making the waiver. 
  
 (d) Severability. If any provision of this Agreement shall be
determined by a court or governmental agency of competent jurisdiction to be invalid, illegal or unenforceable, such invalidity, illegality or unenforceability shall not affect the remainder of this Agreement, which shall remain in full force and
effect and be enforced in accordance with its remaining enforceable terms. 
  
 (e) Assignment. Because of the personal nature of the services to be rendered hereunder, the obligations of Employee under this Agreement may not be delegated or assigned in whole or in part
without the prior written consent of AmeriPath (which consent may be withheld in its sole discretion). However, subject to the foregoing limitation, this Agreement shall be binding upon, and shall insure to the benefit of, the parties hereto and
their respective heirs, devisees, executors, administrators, trustees, legal representatives, successors, transferees and assigns. 
  
 (f) Attorneys’ Fees. In any action or proceeding at law or in equity, including but not limited to arbitration, brought to
enforce or construe any provisions or rights under this Agreement, the unsuccessful party or parties to such litigation or arbitration, as determined by the appropriate court or arbitrator pursuant to a final judgment or decree, shall pay the
successful party or parties all costs, expenses and reasonable attorneys’ fees incurred by such successful party or parties (including but not limited to such costs, expenses and fees in connection with any appeals) and, if such successful
party or parties shall recover judgment in any such action or proceeding, such costs, expenses and attorneys’ fees shall be included as part of such judgment. 
  
 (g) Survival of Certain Provisions. The provisions of Sections 4(a), (e) and (g) (as to expenses
incurred prior to termination), 5, 8 and 9 shall survive the expiration or other termination of this Agreement. 
  

 7 

 (h) Headings and Captions. Headings and captions are included in this Agreement for
purposes of convenience only and are not a part of this Agreement. 
  
 (i) Miscellaneous. Any term used in the plural shall refer to all members of the relevant class and any term used in the singular shall refer to any one or more of the members of the relevant class. References in this
Agreement to articles, sections, paragraphs and exhibits are to articles, sections, paragraphs and exhibits to this Agreement. The terms “herein,” “hereof,” “hereto,” “hereunder” and other terms similar to
such terms refer to this Agreement as a whole and not merely to the specific article, section, paragraph or clause where such terms may appear. 
  
 (j) Counterparts and Facsimile Signatures. Separate copies of this Agreement may be signed by the parties hereto, with the same effect as
though all of the parties had signed one copy of this Agreement. Signatures transmitted by facsimile shall be accepted as original signatures. 
  
 [Signatures on next page] 
  

 8 

 IN WITNESS WHEREOF, the undersigned have duly executed this Employment Agreement as of the
date first written above. 
  

					
	 AMERIPATH:
	 	 AMERIPATH, INC.

			
	 	 	 By
	 	 /s/ Paul B. Queally

	 	 	 	 	 Paul B. Queally

	 	 	 	 	 Chairman of the Executive Committee

			
	 EMPLOYEE:
	 	 	 	 /s/ Donald E. Steen

	 	 	 	 	 Donald E. Steen

  
 The undersigned agrees
to pay to Employee a wholesale rate for travel time on the FlexJet used for travel by Employee between West Palm Beach and Dallas, subject to the terms and limitations described in Section 4(g) above. 
  

					
	 WELSH, CARSON, ANDERSON & STOWE IX, L.P.

		
	 By:
	 	 WCAS IX Partners, L.P.

			
	 	 	By	 	 /s/ Paul B. Queally

	 	 	 	 	                , General Partner

  

 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}]]